Label Mix-Up Spurs Recall of Accord Blood Pressure Meds

Bottle in one of the lots found to contain 100 tablets of spironolactone

Please note: This article was published more than one year ago. The facts and conclusions presented may have since changed and may no longer be accurate. And "More information" links may no longer work. Questions about personal health should always be referred to a physician or other health care professional.

WEDNESDAY, Aug. 29, 2018 (HealthDay News) -- One lot of high blood pressure medication is being recalled after a labeling mix-up, Accord Healthcare Inc. has announced.

The recall is for 100-count bottles of hydrochlorothiazide tablets USP, 12.5 mg, lot PW05264. One of the bottles in that lot was found to contain 100 tablets of spironolactone, a drug used to treat heart failure, cirrhosis of the liver, and other conditions.

Using spironolactone instead of hydrochlorothiazide could have life-threatening consequences for some patients, Accord said. To date, the company has not received any reports of patient harm associated with the recall.

The hydrochlorothiazide tablets are light orange to peach colored, round, biconvex tablets debossed with H on one side and 1 on another side. Patients with Accord hydrochlorothiazide tablets that do not look like this, or those who are unsure, should check with their pharmacist or health care provider for confirmation, the company said. It also advised patients to contact their health care provider if they've had any problems that may be related to taking the recalled medication.

For more information about the recall, contact Accord by phone at 1-855-869-1081.

More Information

Last Updated: